Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Audubon Bioscience provides high-quality human biospecimens and associated clinical data to support cancer and precision medicine research. The company operates a global network of over 120 clinical sites across four continents, offering diverse sample types including tissues, blood products, cells, and biofluids. Their mission centers on enabling early detection and effective treatment of cancer by supplying ethically sourced samples to researchers in academia and industry. They are rapidly growing with more than $16 million in annual revenue as of 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Audubon Bioscience.